SERA

Sera Prognostics, Inc.

5.50 USD

Last updated Dec 8, 06:35 UTC

Yesterday HIGH

$5.67

Yesterday LOW

$4.71

52w HIGH

$9.86

52w LOW

$1.1

EPS

-0.23

PE

-23.91

Next Earnings

Mar 20, 2024

Overview News Insider Transactions Government Trades

Sera Prognostics, Inc. stock is up 179.19% since 30 days ago. The next earnings date is Mar 20, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 December’s closed higher than November.

Sera Prognostics, Inc. develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Stock Exchange

NASDAQ

Sector

Services

Industry

Healthcare

Headquarters

-

Website

www.seraprognostics.com

Happy Mohamed

Wed Mar 22, 2023

Sera Prognostics Q4 EPS $(0.31) Beats $(0.37) Estimate, Sales $65.00K Miss $140.00K Estimate

Sera Prognostics (NASDAQ:SERA) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.37) by 16.22 percent. This is a 24.39 percent increase over losses of $(0.41) per share from
Benzinga Insights

Wed Mar 22, 2023

Earnings Scheduled For March 22, 2023

Companies Reporting Before The Bell • Boyd Gaming (NYSE:BYD) is estimated to report quarterly earnings at $1.09 per share on revenue of $848.27 million.
Benzinga Insights

Tue Mar 21, 2023

Sera Prognostics's Earnings: A Preview
Lisa Levin

Tue Feb 28, 2023

Why Catalyst Biosciences Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket

Gainers Catalyst Biosciences Inc (NASDAQ: CBIO) rose 105% to $0.49 in pre-market trading. South Korea's GC Biopharma said it has signed an asset purchase agreement with Catalyst Biosciences to acquire 3 programs related to the orphan hematology disorders.
Benzinga Insights

Thu Feb 16, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Lisa Levin

Thu Feb 16, 2023

Why Axcella Health Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket

Gainers Axcella Health Inc. (NASDAQ: AXLA) shares rose 54.1% to $0.9290 in pre-market trading after the company announced FDA clearance of its IND application to initiate a phase 2b/3 trial in the U.S. for AXA1125.
Lisa Levin

Wed Feb 15, 2023

Nasdaq Surges 90 Points; Credo Technology Group Shares Slide

U.S. stocks turned mostly higher toward the end of trading, with the Nasdaq Composite gaining around 90 points on Wednesday. The Dow traded down 0.01% to 34,085.88 while the NASDAQ rose 0.76% to 12,050.47. The S&P 500 also rose, gaining, 0.16% to 4,142.69.
Lisa Levin

Wed Feb 15, 2023

Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers Sera Prognostics, Inc. (NASDAQ: SERA) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL.
Lisa Levin

Wed Feb 15, 2023

Gold Down 1%; Roblox Shares Spike Higher

U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 100 points on Wednesday. The Dow traded down 0.34% to 33,974.46 while the NASDAQ rose 0.22% to 11,986.30. The S&P 500 also fell, dropping, 0.19% to 4,128.13.
Benzinga Insights

Wed Feb 15, 2023

12 Health Care Stocks Moving In Wednesday's Intraday Session

Jackson Benjamin, General Counsel

Thu Dec 7, 2023

SERA Recent Insider Trades and Stock Chart

10,000 shares sold
Boniface John J., Chief Scientific Officer

Thu Dec 7, 2023

SERA Recent Insider Trades and Stock Chart

5,000 shares sold